VivoPower PLC (VIVO), a developer of powered land and data center infrastructure for AI compute with operations in Norway, Finland, and the UAE, has no current, verified analyst price targets. The last identifiable sell-side ratings date to 2019–2020 (including an H.C. Wainwright initiation and a William Blair upgrade), well before the company pivoted to its present data center strategy. Some older databases still show a figure near $34, but that reflects Meridian Bioscience, a different company that previously used the VIVO symbol, and is not current coverage of VivoPower.
Because no usable analyst consensus exists, the $3.00 central target here is a fallback objective drawn from public technical discussion rather than a published analyst mean. The $3 round-number level sits just above the roughly $2.90 50-day moving average and is a frequently cited psychological milestone for a stock that traded above $6 earlier in its 52-week range. It should be read as a market-structure reference point, not a forecast. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
VivoPower shares closed near $1.89 on November 9, 2026, giving the company a market capitalization of roughly $60 million. Moving from $1.89 to $3.00 implies upside of approximately 59%, a very large move in percentage terms, though still well inside the stock's 52-week range. The path would most likely depend on the company converting its Mo i Rana data center site in Norway from bitcoin-mining hosting into signed, higher-value AI-compute leases, while demonstrating that its fiscal 2027 results can build on the improvement reported in the first quarter.
The clearest near-term positive is operational. For the unaudited first quarter of fiscal 2027, VivoPower reported revenue of about $6.8 million, net profit of roughly $0.6 million, and positive operating cash flow of about $2.1 million, a sharp improvement over the prior year. Management has also said it is finalizing terms with a prospective data center tenant, and the company continues to pursue the separation of its Tembo electric-vehicle business through a SPAC combination. For a penny stock with a small float, any confirmed AI-compute lease or successful financing event could disproportionately move sentiment.
The obstacles are substantial. For the fiscal year ended June 30, 2026, revenue was only about $2.6 million while the loss from continuing operations widened to roughly $50.4 million, with adjusted EBITDA of about negative $24.4 million. The company disclosed it has not entered into a definitive AI-compute lease for Mo i Rana and that a previously preferred tenant was not pursued. A proposed first 40-megawatt phase carries a preliminary capital cost estimate of roughly $411 million, against net current liabilities of about $11.95 million, related-party loans, and a large unsecured subscription receivable, all of which raise dilution and funding risks.
Technically, the stock remains in a downtrend. The 50-day moving average, near $2.90, sits below the 200-day average near $4.00, a "death cross" configuration that reflects ongoing bearish momentum. Near-term support has been observed around $1.52, while the next meaningful resistance level aligns with prior highs near $6.60. The $3.00 target sits just above the 50-day average and below the 200-day average, meaning a reclaim of that level would be an early sign of trend repair rather than confirmation of a durable reversal.
Analyst price targets normally reflect a research horizon of about 12 months, but because no current analyst targets exist for VivoPower, the $3.00 objective carries no defined time frame. Investors should watch for a definitive AI-compute lease announcement, progress and cost updates on the Mo i Rana conversion, collection of outstanding receivables, dilution from any new financing, and the outcome of the Tembo business combination. Quarterly results and management commentary on tenant negotiations and cash burn will be the most relevant catalysts.
Whether VivoPower can reach $3.00 hinges less on valuation and more on execution: converting its Norwegian data center into signed AI-compute contracts, sustaining the cash-flow improvement reported in early fiscal 2027, and securing capital without excessive dilution. The roughly 59% move required is very large, and the company faces meaningful risks, including wide losses and an unsigned anchor tenant. The $3.00 figure is a technical and psychological reference point rather than an analyst price target, and no reliable analyst consensus exists to guide expectations. The target is reachable only if the operational and financing milestones above materialize, which is far from guaranteed.
I have found Tickeron’s AI Daily Buy/Sell Signals helpful for monitoring names like this one. The platform uses artificial intelligence to track thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on market shifts, technical patterns, and AI analysis. For a volatile stock such as VivoPower, these signals offer a data-driven way to place daily price action in broader context without relying solely on manual review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
VIVO saw its Momentum Indicator move below the 0 level on November 03, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In 74 of the 81 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for VIVO turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 43 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 50-day moving average for VIVO moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VIVO entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VIVO's RSI Oscillator exited the oversold zone, 33 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 64 cases where VIVO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
Following a +30.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIVO advanced for three days, in 184 of 220 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
VIVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. VIVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.173) is normal, around the industry mean (16.272). P/E Ratio (-1.036) is within average values for comparable stocks, (52.956). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.430) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (103.889).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of diagnostic products
Industry ComputerCommunications